$7.86
Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?
Journey Medical (DERM) Q2 2026 Earnings Call Transcript
--B. Riley Adjusts Journey Medical Price Target to $15 From $12, Maintains Buy Rating
Overview
52-week range
$4.31
$9.55
68% of range
Avg surprise (last 3)
-39.3%
Avg reaction (last 2)
-1.0%
50% positive
Latest IV / EM
346%
EM ±66.2% · $8 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.01 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.08 | $-0.07 | -14.3% | +55.6% | +3.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.09 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.16 | $-0.07 | -128.6% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.18 | $-0.24 | +25.0% | — | -5.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.12 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.17 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.53 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.80 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.46 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.57 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $16M | — | $18M | $15M | $13M | — | $15M |
| Cost of revenue | $6M | $6M | — | — | $5M | $5M | — | $5M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $456,000 | $-1M | — | $-2M | $-3M | $-3M | — | $-3M |
| Net income | $-312,000 | $-2M | — | $-2M | $-4M | $-4M | — | $-2M |
| EPS (diluted) | $-0.01 | $-0.08 | — | $-0.09 | $-0.16 | $-0.18 | — | $-0.12 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $26M | $27M | $24M | $25M | $20M | $21M | $20M | $22M |
| Inventory | $8M | $9M | $10M | $12M | $13M | $12M | $14M | $12M |
| Total current assets | $73M | $65M | $67M | $56M | $51M | $54M | $48M | $46M |
| Total assets | $98M | $92M | $95M | $85M | $81M | $85M | $80M | $64M |
| Long-term debt | $20M | $23M | $25M | $20M | $21M | $23M | $25M | $20M |
| Total liabilities | $66M | $61M | $63M | $59M | $62M | $63M | $60M | $53M |
| Total equity | $32M | $31M | $32M | $26M | $19M | $22M | $20M | $11M |